rs369950850
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PM5BP4
The NM_015102.5(NPHP4):c.3161G>A(p.Arg1054His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,599,360 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1054C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_015102.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHP4 | NM_015102.5 | c.3161G>A | p.Arg1054His | missense_variant | 22/30 | ENST00000378156.9 | NP_055917.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHP4 | ENST00000378156.9 | c.3161G>A | p.Arg1054His | missense_variant | 22/30 | 1 | NM_015102.5 | ENSP00000367398 | P2 | |
NPHP4 | ENST00000378169.7 | c.*2062G>A | 3_prime_UTR_variant, NMD_transcript_variant | 19/27 | 1 | ENSP00000367411 | ||||
NPHP4 | ENST00000478423.6 | n.2893G>A | non_coding_transcript_exon_variant | 18/26 | 2 | |||||
NPHP4 | ENST00000489180.6 | c.*972G>A | 3_prime_UTR_variant, NMD_transcript_variant | 25/33 | 2 | ENSP00000423747 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000262 AC: 59AN: 225484Hom.: 0 AF XY: 0.000228 AC XY: 28AN XY: 122566
GnomAD4 exome AF: 0.000124 AC: 180AN: 1447108Hom.: 1 Cov.: 34 AF XY: 0.000127 AC XY: 91AN XY: 718244
GnomAD4 genome AF: 0.000342 AC: 52AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74450
ClinVar
Submissions by phenotype
NPHP4-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 23, 2024 | The NPHP4 c.3161G>A variant is predicted to result in the amino acid substitution p.Arg1054His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.075% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.3161G>A (p.R1054H) alteration is located in exon 22 (coding exon 21) of the NPHP4 gene. This alteration results from a G to A substitution at nucleotide position 3161, causing the arginine (R) at amino acid position 1054 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Senior-Loken syndrome 4;C1847013:Nephronophthisis 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 17, 2022 | - - |
Nephronophthisis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1054 of the NPHP4 protein (p.Arg1054His). This variant is present in population databases (rs369950850, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with NPHP4-related conditions. ClinVar contains an entry for this variant (Variation ID: 578586). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPHP4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 22, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at